App-based rehab may match in-person therapy for athletes with knee pain

NCT ID NCT07693634

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study compares a mobile app-based rehabilitation program to traditional in-person physiotherapy for recreational athletes aged 18–35 with patellofemoral pain syndrome (pain around the kneecap). Both groups follow the same exercise plan for four weeks, but one group does it remotely using the Physitrack app with virtual supervision. The trial measures pain, knee movement, and quality of life to see if the app-based approach is a practical and effective alternative.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tele-rehabilitation program via Physitrack mobile app
What this could lead to
If effective, this could offer a convenient, home-based alternative to in-person physiotherapy for athletes with knee pain, making rehabilitation more accessible.
What could go wrong
This is a small, early-stage trial with only 26 participants, so results may not apply to all athletes. The tele-rehab approach may be less effective than in-person therapy for some individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATELLOFEMORAL PAIN SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Rehabilitation Sciences, The University of Faisalabad

    RECRUITING

    Faisalābad, Punjan, 38000, Pakistan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.